Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
3.950
+0.140 (3.67%)
At close: Aug 1, 2025, 4:00 PM
3.930
-0.020 (-0.51%)
After-hours: Aug 1, 2025, 4:10 PM EDT
Chimerix Market Cap
Karyopharm Therapeutics has a market cap or net worth of $33.95 million as of August 1, 2025. Its market cap has decreased by -70.58% in one year.
Market Cap
33.95M
Enterprise Value
224.22M
1-Year Change
-70.58%
Ranking
Category
Stock Price
$3.95
Market Cap Chart
Since November 6, 2013, Karyopharm Therapeutics's market cap has decreased from $442.90M to $33.95M, a decrease of -92.33%. That is a compound annual growth rate of -19.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 34.00M | -59.86% |
| Dec 31, 2024 | 84.70M | -14.53% |
| Dec 29, 2023 | 99.10M | -64.08% |
| Dec 30, 2022 | 275.90M | -43.21% |
| Dec 31, 2021 | 485.80M | -57.36% |
| Dec 31, 2020 | 1.14B | -5.35% |
| Dec 31, 2019 | 1.20B | 111.62% |
| Dec 31, 2018 | 568.80M | 25.59% |
| Dec 29, 2017 | 452.90M | 16.82% |
| Dec 30, 2016 | 387.70M | -18.12% |
| Dec 31, 2015 | 473.50M | -61.32% |
| Dec 31, 2014 | 1.22B | 79.50% |
| Dec 31, 2013 | 681.90M | 53.96% |
| Nov 6, 2013 | 442.90M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 664.39B |
| Johnson & Johnson | 396.75B |
| AbbVie | 333.89B |
| AstraZeneca | 232.21B |
| UnitedHealth Group | 226.39B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.63B |
| Novo Nordisk | 213.92B |